Professor in Pediatrics, Northwestern University Medical School

Pediatric Hematology & Oncology

Dr. Alexis A. Thompson, MD

Alexis Thompson practices Pediatric Hematology & Oncology. She went to Tulane University School of Medicine. She received awards:"Regional Top Doctor". Alexis Thompson is a published MD. She published 41 publications, including: 'Unrelated donor stem cell transplantation for transfusion-dependent thalassemia.'

Publications

Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with Sickle cell anaemia-TCD With Transfusions Changing...
Effects of hydroxyurea treatment for patients with hemoglobin SC Disease.
Organ iron accumulation in chronically transfused children with Sickle cell anaemia: baseline results from the TWiTCH trial.
Mutations in TRNT1, encoding the CCA-adding enzyme, cause congenital sideroblastic Anemia with B cell immunodeficiency, periodic fevers and developmental delay (SIFD).
Controlled trial of transfusions for silent cerebral infarcts in sickle cell Anemia.
Silent cerebral infarction, income and grade retention among students with Sickle cell.
Randomization is not associated with socio-economic and demographic factors in a multi-center clinical trial of children with sickle cell Anemia.
Relationship among chelator adherence, change in chelators, and quality of life in Thalassemia.
Access to Patient-Centered Medical Homes in Children with Sickle Cell Disease.
Thalassemias.
Endogenous factor VIII synthesis from the intron 22-inverted F8 locus may modulate the immunogenicity of replacement therapy for Hemophilia A.
Pregnancy outcomes in women with Thalassemia in North America and the United Kingdom.
Shwachman-Diamond Syndrome: Diarrhea, no Longer Required?
Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention.
Evaluation of the SCKnowIQ Tool and Reproductive CHOICES Intervention Among Young Adults With Sickle Cell Disease or Sickle Cell Trait.
Alloimmunization in Sickle Cell Anemia in the Era of Extended Red Cell Typing.
Sickle cell disease and racism: real or false barriers?
Human T Cell Lymphotropic Virus Type 1 Infection Among U.S. Thalassemia Patients.
Genetic and Clinical Determinants Influencing Warfarin Dosing in Children With Heart Disease.
Associated risk factors for silent cerebral infarcts in sickle cell Anemia: low baseline hemoglobin, gender and relative high systolic blood pressure.
Risks factors and mortality associated with an elevated tricuspid-regurgitant-jet-velocity measured by Doppler-echocardiography in Thalassemia: a Thalassemia Clinical ...
Acute chest syndrome is associated with history of asthma in hemoglobin SC Disease.
Response to steroids predicts response to rituximab in pediatric chronic Immune thrombocytopenia.
Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with Sickle cell disease.
What is the evidence for using hydroxyurea for secondary stroke prevention?
Primary prophylaxis in Sickle cell disease: is it feasible? Is it effective?
The impact of Thalassemia on Southeast Asian and Asian Indian families in the United States: a qualitative study.
Reproducibility of tricuspid regurgitant jet velocity measurements in children and young adults with Sickle cell disease undergoing screening for pulmonary hypertension.
Parental attitudes toward research participation in pediatric Sickle cell disease.
Elevated soluble transferrin receptor levels reflect increased erythropoietic drive rather than iron deficiency in pediatric Sickle cell disease.
Functional capacity in children and young adults with Sickle cell disease undergoing evaluation for cardiopulmonary disease.
Prolonged QTc interval in children and young adults with Sickle cell disease at steady state.
Tricuspid regurgitant jet velocity elevation and its relationship to lung function in pediatric Sickle cell disease.
Sudden-onset blindness in Sickle cell disease due to retinal artery occlusion.
Prophylaxis versus episodic treatment to prevent joint disease in boys with severe Hemophilia.
R2* imaging of transfusional iron burden at 3T and comparison with 1.5T.
HOXA11 mutation in amegakaryocytic thrombocytopenia with radio-ulnar synostosis syndrome inhibits megakaryocytic differentiation in vitro.
Advances in the management of Sickle cell disease.
Reproductive Health Choices for Young Adults With Sickle Cell Disease or Trait: Randomized Controlled Trial Immediate Posttest Effects.
Unrelated donor stem Cell transplantation for transfusion-dependent thalassemia.

Schools

Tulane University School Of Medicine
Children39s Hospital Of L A
Children39s Hospital Philadelphia

Conditions Treated

Anemia
Coagulation Disorders (incl. Hemophilia)
Immune Thrombocytopenic Purpura (ITP)
Leukocytosis
View All

Doctors Specialties

Pediatric Hematology
Oncology

Accepted Insurances

Awards

Regional Top Doctor

Education

Children's Hospital of Philadelphia
Children's Hospital of Los Angeles
Tulane University School of Medicine

Hospital

Lurie Children's Hospital of Chicago
Northwestern Memorial Hospital
Ann & Robert H. Lurie Children?

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Nobuko Hijiya, MD This Doctor is OpenDoctor Recommended.
	Dr. John F. Shern, MD This Doctor is OpenDoctor Recommended.
	Dr. Radhika R. Peddinti, MD This Doctor is OpenDoctor Recommended.
	Dr. Jennifer Reichek, MD This Doctor is OpenDoctor Recommended.
	Dr. Reggie E. Duerst, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Peter A. Noronha, MD This Doctor is OpenDoctor Recommended.
	Dr. William T. Tse, MD This Doctor is OpenDoctor Recommended.
	Dr. Irene Eftekhar, MD This Doctor is OpenDoctor Recommended.
	Dr. John M. Cunningham, MD This Doctor is OpenDoctor Recommended.